Epilepsy Therapeutics
Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characteriz ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Epigenetic Market Size Growth Rate by Type (2021-2027) 1.2.2 Reagents 1.2.3 Kits 1.2.4 Instruments 1.2.5 Enzymes 1.2.6 Services 1.3 Market by Application 1.3.1 Global Epigenetic Market Share by Application (2021-2027) 1.3.2 Academic Research Institutes 1.3.3 Biotechnology Companies 1.3.4 Biopharmaceutical Companies 1.3.5 Diagnostic Companies 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Epigenetic Market Size 2.2 Epigenetic Market Size by Regions 2.2.1 Epigenetic Growth Rate by Regions (2021-2027) 2.2.2 Epigenetic Market Share by Regions (2021-2027) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 Epigenetic Revenue by Players (2020-2021) 3.2 Epigenetic Key Players Headquaters and Area Served 3.3 Key Players Epigenetic Product/Solution/Service 3.4 Date of Enter into Epigenetic Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global Epigenetic Market Size by Type (2021-2027) 4.2 Global Epigenetic Market Size by Application (2021-2027) 5 North America 5.1 North America Epigenetic Market Forecast (2021-2027) 5.2 Epigenetic Key Players in North America 5.3 North America Epigenetic Market Size by Type 5.4 North America Epigenetic Market Size by Application 6.4.4 Canada 6 Europe 6.1 Europe Epigenetic Market Forecast (2021-2027) 6.2 Epigenetic Key Players in Europe 6.3 Europe Epigenetic Market Size by Type 6.4 Europe Epigenetic Market Size by Application 7 Japan 7.1 Japan Epigenetic Market Forecast (2021-2027) 7.2 Epigenetic Key Players in Europe 7.3 Japan Epigenetic Market Size by Type 7.4 Japan Epigenetic Market Size by Application 8 Rest of World 8.1 China 8.1.1 China Epigenetic Market Analysis 8.1.2 Key Players in China 8.2 Southeast Asia 8.2.1 Southeast Asia Epigenetic Market Analysis 8.2.2 Key Players in Southeast Asia 8.3 India 8.3.1 India Epigenetic Market Analysis 8.3.2 Key Players in India 9 International Player Profiles 9.1 Illumina 9.1.1 Illumina Company Details 9.1.2 Illumina Description and Business Overview 9.1.3 Illumina Epigenetic Introduction 9.1.4 Illumina Revenue in Epigenetic Business (2020-2021) 9.1.5 Illumina Recent Development 9.2 Qiagen 9.2.1 Qiagen Company Details 9.2.2 Qiagen Description and Business Overview 9.2.3 Qiagen Epigenetic Introduction 9.2.4 Qiagen Revenue in Epigenetic Business (2020-2021) 9.2.5 Qiagen Recent Development 9.3 Abcam 9.3.1 Abcam Company Details 9.3.2 Abcam Description and Business Overview 9.3.3 Abcam Epigenetic Introduction 9.3.4 Abcam Revenue in Epigenetic Business (2020-2021) 9.3.5 Abcam Recent Development 9.4 Merck & Co 9.4.1 Merck & Co Company Details 9.4.2 Merck & Co Description and Business Overview 9.4.3 Merck & Co Epigenetic Introduction 9.4.4 Merck & Co Revenue in Epigenetic Business (2020-2021) 9.4.5 Merck & Co Recent Development 9.5 Sigma-Aldrich 9.5.1 Sigma-Aldrich Company Details 9.5.2 Sigma-Aldrich Description and Business Overview 9.5.3 Sigma-Aldrich Epigenetic Introduction 9.5.4 Sigma-Aldrich Revenue in Epigenetic Business (2020-2021) 9.5.5 Sigma-Aldrich Recent Development 9.6 New England Biolabs 9.6.1 New England Biolabs Company Details 9.6.2 New England Biolabs Description and Business Overview 9.6.3 New England Biolabs Epigenetic Introduction 9.6.4 New England Biolabs Revenue in Epigenetic Business (2020-2021) 9.6.5 New England Biolabs Recent Development 9.7 Thermo Fisher Scientific 9.7.1 Thermo Fisher Scientific Company Details 9.7.2 Thermo Fisher Scientific Description and Business Overview 9.7.3 Thermo Fisher Scientific Epigenetic Introduction 9.7.4 Thermo Fisher Scientific Revenue in Epigenetic Business (2020-2021) 9.7.5 Thermo Fisher Scientific Recent Development 9.8 Diagenode 9.8.1 Diagenode Company Details 9.8.2 Diagenode Description and Business Overview 9.8.3 Diagenode Epigenetic Introduction 9.8.4 Diagenode Revenue in Epigenetic Business (2020-2021) 9.8.5 Diagenode Recent Development 9.9 Active Motif 9.9.1 Active Motif Company Details 9.9.2 Active Motif Description and Business Overview 9.9.3 Active Motif Epigenetic Introduction 9.9.4 Active Motif Revenue in Epigenetic Business (2020-2021) 9.9.5 Active Motif Recent Development 9.10 Roche Diagnostics 9.10.1 Roche Diagnostics Company Details 9.10.2 Roche Diagnostics Description and Business Overview 9.10.3 Roche Diagnostics Epigenetic Introduction 9.10.4 Roche Diagnostics Revenue in Epigenetic Business (2020-2021) 9.10.5 Roche Diagnostics Recent Development 9.11 Eisai 9.11.1 Eisai Company Details 9.11.2 Eisai Description and Business Overview 9.11.3 Eisai Epigenetic Introduction 9.11.4 Eisai Revenue in Epigenetic Business (2020-2021) 9.11.5 Eisai Recent Development 9.12 Novartis 9.12.1 Novartis Company Details 9.12.2 Novartis Description and Business Overview 9.12.3 Novartis Epigenetic Introduction 9.12.4 Novartis Revenue in Epigenetic Business (2020-2021) 9.12.5 Novartis Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details
List of Tables Table 1. Global Epigenetic Market Size Growth Rate by Type (2021-2027) (US$ Million) Table 2. Key Players of Reagents Table 3. Key Players of Kits Table 4. Key Players of Instruments Table 5. Key Players of Enzymes Table 6. Key Players of Services Table 7. Global Epigenetic Market Size Growth by Application (2021-2027) (US$ Million) Table 8. Global Epigenetic Market Size by Regions (2021-2027) (US$ Million) Table 9. Global Epigenetic Market Share by Regions (2021-2027) Table 10. Market Top Trends Table 11. Market Use Cases Table 12. Global Epigenetic Revenue by Players (2020-2021) (US$ Million) Table 13. Global Epigenetic Market Share by Players (2020-2021) Table 14. Key Players Headquarters and Area Served Table 15. Key Players Epigenetic Product Solution and Service Table 16. Date of Enter into Epigenetic Market Table 17. Mergers & Acquisitions, Expansion Plans Table 18. Global Epigenetic Market Size by Type (2021-2027) (US$ Million) Table 19. Global Epigenetic Market Size Share by Type (2021-2027) Table 20. Global Epigenetic Market Size by Application (2021-2027) (US$ Million) Table 21. Global Epigenetic Market Size Share by Application (2021-2027) Table 22. North America Key Players Epigenetic Revenue (2020-2021) (US$ Million) Table 23. North America Key Players Epigenetic Market Share (2020-2021) Table 24. North America Epigenetic Market Size by Type (2021-2027) (US$ Million) Table 25. North America Epigenetic Market Share by Type (2021-2027) Table 26. North America Epigenetic Market Size by Application (2021-2027) (US$ Million) Table 27. North America Epigenetic Market Share by Application (2021-2027) Table 28. Europe Key Players Epigenetic Revenue (2020-2021) (US$ Million) Table 29. Europe Key Players Epigenetic Market Share (2020-2021) Table 30. Europe Epigenetic Market Size by Type (2021-2027) (US$ Million) Table 31. Europe Epigenetic Market Share by Type (2021-2027) Table 32. Europe Epigenetic Market Size by Application (2021-2027) (US$ Million) Table 33. Europe Epigenetic Market Share by Application (2021-2027) Table 34. Japan Key Players Epigenetic Revenue (2020-2021) (US$ Million) Table 35. Japan Key Players Epigenetic Market Share (2020-2021) Table 36. Japan Epigenetic Market Size by Type (2021-2027) (US$ Million) Table 37. Japan Epigenetic Market Share by Type (2021-2027) Table 38. Japan Epigenetic Market Size by Application (2021-2027) (US$ Million) Table 39. Japan Epigenetic Market Share by Application (2021-2027) Table 40. Key Players in China Table 41. Key Players in Southeast Asia Table 42. Key Players in India Table 43. Illumina Company Details Table 44. Illumina Description and Business Overview Table 45. Illumina Epigenetic Product Table 46. Illumina Revenue in Epigenetic Business 2020 and 2021 Table 47. Illumina Recent Development Table 48. Qiagen Company Details Table 49. Qiagen Description and Business Overview Table 50. Qiagen Epigenetic Product Table 51. Qiagen Revenue in Epigenetic Business 2020 and 2021 Table 52. Qiagen Recent Development Table 53. Abcam Company Details Table 54. Abcam Description and Business Overview Table 55. Abcam Epigenetic Product Table 56. Abcam Revenue in Epigenetic Business 2020 and 2021 Table 57. Abcam Recent Development Table 58. Merck & Co Company Details Table 59. Merck & Co Description and Business Overview Table 60. Merck & Co Epigenetic Product Table 61. Merck & Co Revenue in Epigenetic Business 2020 and 2021 Table 62. Merck & Co Recent Development Table 63. Sigma-Aldrich Company Details Table 64. Sigma-Aldrich Description and Business Overview Table 65. Sigma-Aldrich Epigenetic Product Table 66. Sigma-Aldrich Revenue in Epigenetic Business 2020 and 2021 Table 67. Sigma-Aldrich Recent Development Table 68. New England Biolabs Company Details Table 69. New England Biolabs Description and Business Overview Table 70. New England Biolabs Epigenetic Product Table 71. New England Biolabs Revenue in Epigenetic Business 2020 and 2021 Table 72. New England Biolabs Recent Development Table 73. Thermo Fisher Scientific Company Details Table 74. Thermo Fisher Scientific Description and Business Overview Table 75. Thermo Fisher Scientific Epigenetic Product Table 76. Thermo Fisher Scientific Revenue in Epigenetic Business 2020 and 2021 Table 77. Thermo Fisher Scientific Recent Development Table 78. Diagenode Company Details Table 79. Diagenode Description and Business Overview Table 80. Diagenode Epigenetic Product Table 81. Diagenode Revenue in Epigenetic Business 2020 and 2021 Table 82. Diagenode Recent Development Table 83. Active Motif Company Details Table 84. Active Motif Description and Business Overview Table 85. Active Motif Epigenetic Product Table 86. Active Motif Revenue in Epigenetic Business 2020 and 2021 Table 87. Active Motif Recent Development Table 88. Roche Diagnostics Company Details Table 89. Roche Diagnostics Description and Business Overview Table 90. Roche Diagnostics Epigenetic Product Table 91. Roche Diagnostics Revenue in Epigenetic Business 2020 and 2021 Table 92. Roche Diagnostics Recent Development Table 93. Eisai Company Details Table 94. Eisai Description and Business Overview Table 95. Eisai Epigenetic Product Table 96. Eisai Revenue in Epigenetic Business 2020 and 2021 Table 97. Eisai Recent Development Table 98. Novartis Company Details Table 99. Novartis Description and Business Overview Table 100. Novartis Epigenetic Product Table 101. Novartis Revenue in Epigenetic Business 2020 and 2021 Table 102. Novartis Recent Development Table 103. Epigenetic Market Trends Table 104. Epigenetic Market Drivers Table 105. Epigenetic Market Challenges Table 106. Epigenetic Market Restraints Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Global Epigenetic Market Share by Type in 2021 & 2027 Figure 2. Reagents Features Figure 3. Kits Features Figure 4. Instruments Features Figure 5. Enzymes Features Figure 6. Services Features Figure 7. Global Epigenetic Market Share by Application in 2021 & 2027 Figure 8. Academic Research Institutes Case Studies Figure 9. Biotechnology Companies Case Studies Figure 10. Biopharmaceutical Companies Case Studies Figure 11. Diagnostic Companies Case Studies Figure 12. Epigenetic Report Years Considered Figure 13. Global Epigenetic Market Size and Growth Rate (2020-2027) (US$ Million) Figure 14. Global Epigenetic Market Share by Regions (2020-2027) Figure 15. Global Epigenetic Market Share by Players in 2021 Figure 16. Global Epigenetic Market Size Market Share by Type (2021-2027) Figure 17. Global Epigenetic Market Size Market Share by Application (2021-2027) Figure 18. Global Epigenetic Revenue Market Share by Application in 2021 Figure 19. North America Epigenetic Market Size 2021-2027 (US$ Million) Figure 20. Europe Epigenetic Market Size 2021-2027 (US$ Million) Figure 21. Japan Epigenetic Market Size 2021-2027 (US$ Million) Figure 22. Epigenetic Market Size in China (2021-2027) (US$ Million) Figure 23. Epigenetic Market Size in Southeast Asia (2021-2027) (US$ Million) Figure 24. Epigenetic Market Size in India (2021-2027) (US$ Million) Figure 25. Bottom-up and Top-down Approaches for This Report Figure 26. Data Triangulation Figure 27. Key Executives Interviewed
Illumina Qiagen Abcam Merck & Co Sigma-Aldrich New England Biolabs Thermo Fisher Scientific Diagenode Active Motif Roche Diagnostics Eisai Novartis
Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characteriz ... Read More
E-prescribing or electronic prescribing (e-Rx) is the electronic transmission of prescriptions fr ... Read More
Escherichia coli (E. coli), is a bacterium which normally lives in the intestines of humans and a ... Read More
Patient tracking is a refined process intended to screen patient’s movements, outside conventio ... Read More